AMSTERDAM—Postoperative radiotherapy to the internal mammary and supraclavicular lymph nodes in women whose breast cancer has been successfully treated and are at low risk of relapse could save lives in the long term, according to research findings reported at the 2013 European Cancer Conference in Amsterdam (September 30th to October 1st). Patients who had one or more nodes involved, or had a centrally located tumor had a significant reduction in the risk of dying when treated with chest nodal irradiation in the EORTC Cancer Groups phase III trial 22922-10925 with 4004 patients recruited between 1996 – 2004 who were followed for a median of 11 years. Dr Philip Poortmans from the Institute Verbeeten in Tilburg, Netherlands, gave AudioMedica.com the details. Professor Ian Kunkler from Edinburgh University and Professor John Yarnold from the Institute of Cancer Research in London added comments. Peter Goodwin and Sarah Maxwell report.
You may also like...
Metastatic Colorectal Cancer: Capecitabine Equivalent to 5-FU in Irinotecan/Bevacizumab Combos 5 Aug, 2009 Cabozantinib Better for VEGF Resistant Metastatic Renal Cell Carcinoma 20 Apr, 2017 Treating HER 2 positive metastatic breast cancer without chemotherapy? 9 Apr, 2013 Breast cancer chemoprevention: meta-analysis shows SERMs are highly effective 1 May, 2013
- Previous story Diabetes increases risk of breast and colon cancer
- Next story Big steps forward for advanced melanoma treatment
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014